CLARVEX

Evidence
before scale.

The Lab defines what needs to be learned, how it will be tested and what evidence is needed before committing to the next stage.

Six stages. A decision at every gate.

Each stage records its question, findings, limitations and next decision. Work may advance, return to an earlier stage, pause or close; a promising result does not automatically authorise the next commitment.

00

Intake

Start with the right question.

Record the problem, its context and the origin of the information. Identify initial restrictions and decide whether discovery is justified.

Evidence expected
A clear problem statement, the source of the information and the initial constraints.
Gate question
Is there enough information to investigate?
Possible decisions
Proceed, hold, decline or request clarification.
01

Discovery

Understand before you assume.

Investigate the people, setting and existing alternatives. Make assumptions explicit before committing to a solution.

Evidence expected
Problem evidence, a defined user or context, and a list of critical uncertainties.
Gate question
Is the problem understood well enough?
Possible decisions
Advance, repeat discovery, hold or close.
02

Feasibility

Test the essential assumptions.

Examine technical and commercial assumptions alongside ownership, privacy, security, safety and resource constraints. Define what a prototype should test.

Evidence expected
A plausible technical approach, a plan for the material risks and measurable prototype criteria.
Gate question
Is there a responsible path to a prototype?
Possible decisions
Prototype, investigate further, hold or close.
03

Prototype

Make the question tangible.

Build only what is needed to test the agreed hypotheses. Record results, defects and failed assumptions alongside the prototype’s limitations.

Evidence expected
Test results, limitations and a clear proposal for any further evaluation.
Gate question
What does the evidence actually show?
Possible decisions
Pilot, iterate, hold or close.
04

Pilot

Learn in the real context.

Evaluate agreed assumptions in a controlled real or representative setting. Define the participants, duration, safeguards, responsibilities and success criteria before testing.

Evidence expected
Actual results compared with the agreed criteria, including unresolved risks.
Gate question
Does the approach hold up in practice?
Possible decisions
Consider a venture route, run further tests, hold or close.
05

Venture

Consider the next commitment.

Review the value proposition, ownership, commercial pathway and responsibilities. Commercialisation requires the relevant corporate approvals.

Evidence expected
A supported commercialisation thesis, rights review and responsible operating owner.
Gate question
Is the next commitment justified?
Possible decisions
Approve a route, approve conditionally, return to research, hold or close.

A question
made testable.

Hypothetical example: could equipment observations help a maintenance reviewer decide whether an inspection is needed?

Discovery would examine the current review process and available records. Feasibility would ask whether those records are reliable enough for a useful test. A prototype could then organise simulated observations into an evidence record for a reviewer.

Evaluation would compare that review against agreed criteria, including missed conditions and unnecessary alerts. The findings could support further testing, revision or closure; they would not by themselves justify live deployment.

This illustrates the method; it is not a CLARVEX project or a validated result.

01

Record what is known

Document the method, results and limitations so that decisions can be traced to evidence.

02

Keep risks visible

Consider safety, privacy, security, ownership and practical constraints throughout the work.

03

Separate evidence from authority

A stage recommendation does not itself authorise spending, contracts or publication.

BUILD WHAT MATTERS.

Discuss a research question.

Contact CLARVEX

Describe the question, the setting, the evidence already available and any constraints on testing or access.